New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
13:01 EDTAAgilent enters strategic partnership with Sera Prognostics
Agilent Technologies (A) and Sera Prognostics Inc., a women's health company, announced a strategic partnership to develop proteomic assays for the early prediction of pregnancy complications. Sera Prognostics is currently developing a novel test for the early prediction of preterm birth risk using advanced proteomic science. Agilent is a leading provider of a wide range of analytical instrumentation, including liquid chromatography, mass spectrometry and automation systems. As part of the partnership, Sera Prognostics purchased multiple Agilent 1290 Infinity ultra high-performance liquid chromatography systems, 6490 iFunnel triple quadrupole mass spectrometry systems and 1260 Infinity LC systems with ultraviolet detectors and is adapting Agilent's automated sample-preparation technologies for production. The partners will develop high-throughput workflows for sample preparation and mass-spectrometry analysis. To meet the demands of high-volume testing, Sera Prognostics expects to leverage Agilent's novel automated sample-prep technology and other automation, including the AssayMAP Bravo and RapidFire fast liquid chromatography together with ultra-sensitive ion funnel triple quadrupole mass spectrometry.
News For A From The Last 14 Days
Check below for free stories on A the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
16:09 EDTAAgilent sees FY14 EPS $3.04-$3.08, consensus $3.07
Sees FY14 revenue $6.99B-$7.03B, consensus $6.99B
16:08 EDTAAgilent sees Q4 EPS 87c-91c, consensus 94c
Subscribe for More Information
16:06 EDTAAgilent reports Q3 EPS 78c, consensus 74c
Subscribe for More Information
15:03 EDTANotable companies reporting after market close
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use